<DOC>
	<DOCNO>NCT00532246</DOCNO>
	<brief_summary>The purpose study measure carotid artery IMT single visit subset woman previously enrol CORE ( H3S-MC-GGJY ) trial</brief_summary>
	<brief_title>Carotid Artery Intima-Media Thickness Following Exposure Raloxifene Placebo</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Raloxifene Hydrochloride</mesh_term>
	<criteria>Patients must complete Eli Lilly Company clinical trial CORE ( H3SMCGGJY ) inclusive visit 5 , one 9 participate study site California . Patients must dispense study drug CORE trial ( H3SMCGGJY ) . Have receive treatment within last 30 day drug receive regulatory approval indication time study entry Have previously withdraw exploratory study study investigate raloxifene Are employ Eli Lilly Company ( , employee , temporary contract worker , designees responsible conduct study ) . Immediate family Eli Lilly Company employee may participate Lillysponsored clinical trial , permit participate Eli Lilly Company facility . Immediate family define spouse , parent , child , sibling , whether biological legally adopt Are investigator site personnel directly affiliate study , immediate family investigator site personnel directly affiliate study . Immediate family define spouse , parent , child , sibling , whether biological legally adopt</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>